Panacos Pharmaceuticals, Inc.(PANC), is a development stage biotechnology company. Recently their CEO and CFO have bought larget amounts of shares amid rumors of the company's buyout. The officers bought shares in the mid $5 range. Right now shares are trading above $6. I'd like to see a pullback to below $5.90 before buying.
I'll add them to my buy list, since I always see CFO purchases as extremely positive for a company.